USPH · XBRL financial data

U S Physical Therapy financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (USPH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	423	495	553	605	671	781
Revenue from contracts with customers	423	495	553	605	671	781
Gross profit	94	117	112	122	124	150
Selling, general and administrative	42	47	46	52	58	69
Operating income (loss)	52	71	57	52	63	87
Interest income	—	0	0	4	4	0
Other income (expense)	—	0	1	0	0	0
Income tax expense (benefit)	13	15	12	12	15	20
Net income (loss)	35	41	32	28	31	40
Earnings per share, basic USD per share	2.48	2.41	2.25	1.28	1.84	1.42
Earnings per share, diluted USD per share	2.48	2.41	2.25	1.28	1.84	1.42
Weighted average shares, basic millions of shares	13	13	13	14	15	15
Weighted average shares, diluted millions of shares	13	13	13	14	15	15

Fiscal years (USPH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	33	29	32	153	41	36
Accounts receivable	42	46	52	52	59	64
Total current assets	88	95	111	233	138	140
Property and equipment, net	22	23	25	26	32	36
Right-of-use asset	82	96	103	103	134	144
Goodwill	346	435	494	510	667	692
Total assets	594	749	858	997	1,167	1,204
Accrued liabilities	60	46	37	55	60	81
Current portion of long-term debt	5	1	8	8	11	10
Total current liabilities	93	83	85	102	116	139
Long-term debt	17	118	176	139	143	153
Lease liability, non-current	62	74	78	77	102	111
Total liabilities	184	297	374	345	408	434
Retained earnings	212	224	233	224	227	227
Total stockholders' equity	276	296	316	476	489	476
Total liabilities and equity	594	749	858	997	1,167	1,204
Common shares outstanding (cover page) millions of shares	13	13	13	15	15	15

Fiscal years (USPH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	35	41	32	28	31	40
Stock-based compensation	8	8	7	7	8	8
Depreciation and amortization	11	12	15	16	19	22
Net cash from operating activities	100	76	59	82	75	75
Net cash from investing activities	(51)	(124)	(81)	(45)	(149)	(37)
Proceeds from issuing common stock	—	0	0	164	0	0
Share repurchases	—	—	—	0	0	6
Dividends paid	4	19	21	24	27	27
Proceeds from long-term debt	0	0	150	0	0	—
Repayments of long-term debt	0	0	2	4	4	9
Net cash from financing activities	(39)	43	26	84	(37)	(44)
Net change in cash	9	(4)	3	121	(111)	(6)

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
U S Physical Therapy	25	214	34*	14.9M	—	Q2 FY26 10-QJun 30, 2026
LifeStance Health Group	226	435	100*	382.1M	—	Q2 FY26 10-QJun 30, 2026
Pennant Group	18	302	not reported	35.1M	—	Q3 FY26 10-QSep 30, 2026
Omada Health	222	88	4*	61.2M	—	Q2 FY26 10-QJun 30, 2026
Talkspace	39	62	11*	165.8M	—	Q2 FY26 10-QJun 30, 2026
GeneDx Holdings	60	114	(29)*	29.8M	4.6 quarters	Q2 FY26 10-QJun 30, 2026
Privia Health Group	412	not reported	1.1*	127.7M	—	Q2 FY26 10-QJun 30, 2026
Strata Critical Medical	35	74	9.5*	89.3M	—	Q3 FY26 10-QSep 30, 2026
DocGo	25	73	(9.2)*	98.9M	2.7 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.